ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PLSE vs ICUI // RETURN ON INVESTED CAPITAL (ROIC)

Pulse Biosciences Inc (NASDAQ) VS. ICU Medical Inc. (NASDAQ) • 15-METRIC TALLY: PLSE 1 — ICUI 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ICUI
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PLSE VS. ICUI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PLSE ICUI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 36.80% -66.80 ICUI /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -30.70% 1.00% -31.70 ICUI /roic <GO>
EV/EBITDA & P/E Valuation — 46.6x — TIE /valuation <GO>
Free Cash Flow Yield -1.38% 2.18% -3.56 ICUI /fcf-yield <GO>
Operating Margin -60.00% 1.90% -61.90 ICUI /operating-margins <GO>
Net Profit Margin -60.00% 0.00% -60.00 ICUI /net-margins <GO>
Revenue Growth (YoY) — -6.30% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 8/9 -6.00 ICUI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.1 50.1 +3.03 PLSE /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.96B $4.22B -$260.5M ICUI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PLSE REV ICUI REV PLSE GROSS % ICUI GROSS % PLSE FCF ICUI FCF
FY 2025 $350.0K $2.23B -50.0% 36.8% -$54.4M $91.8M
FY 2024 $0 $2.38B — 34.6% -$36.5M $124.7M
FY 2023 $0 $2.26B — — -$33.0M $166.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PLSE // BETA —
ICUI // BETA —